Clinical Trial Update: A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cladribine added to interferon-beta in active multiple sclerosis; study completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cladribine (cladribine)
• Interferon-beta (interferon beta)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2013-07-01